E. Nakazawa

发表

The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.

K. Hirata, K. Kamiguchi, M. Asaka, 2011, Experimental and molecular pathology.

Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5

T. Yamashita, N. Sato, T. Tsukahara, 2006, Cancer science.

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

K. Hirata, K. Kamiguchi, M. Greene, 2009, Journal of immunotherapy.

Establishment of a monoclonal anti‐pan HLA class I antibody suitable for immunostaining of formalin‐fixed tissue: Unusually high frequency of down‐regulation in breast cancer tissues

N. Sato, T. Hasegawa, Y. Tamura, 2012, Pathology international.

Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4

K. Kamiguchi, N. Sato, T. Hasegawa, 2009, Cancer science.

Expression and function of FERMT genes in colon carcinoma cells.

K. Hirata, N. Sato, T. Hasegawa, 2013, Anticancer research.

ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells.

Shuji Takahashi, K. Kamiguchi, N. Sato, 2012, Carcinogenesis.

Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.

N. Sato, H. Kitamura, Y. Hirohashi, 2006, Urology.

Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells

Shuji Takahashi, N. Sato, Y. Tamura, 2013, Pathology international.

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

K. Hirata, K. Kamiguchi, M. Greene, 2009, Journal of immunotherapy.

Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4

K. Kamiguchi, N. Sato, T. Hasegawa, 2009, Cancer science.